| US 7,608,695 B2 | ||
| Substance with antithrombotic activity and method for detecting glycokallidin | ||
| Naoyuki Fukuchi, Kawasaki (Japan); Fumie Futaki, Kawasaki (Japan); Morikazu Kito, Kawasaki (Japan); Seiichi Sato, Kawasaki (Japan); Takayuki Kajiura, Kawasaki (Japan); Yukitsugu Ono, Kawasaki (Japan); Koichi Ishii, Kawasaki (Japan); Akiko Tanaka, Kawasaki (Japan); Junko Shinozaki, Kawasaki (Japan); and Yasuko Jojima, Kawasaki (Japan) | ||
| Assigned to Ajinomoto Co., Inc., Tokyo (Japan) | ||
| Filed on Apr. 16, 2004, as Appl. No. 10/825,127. | ||
| Application 10/825127 is a continuation of application No. 09/673245, granted, now 6,878,811, previously published as PCT/JP99/00089, filed on Jan. 13, 1999. | ||
| Claims priority of application No. 10-113962 (JP), filed on Apr. 23, 1998. | ||
| Prior Publication US 2004/0229288 A1, Nov. 18, 2004 | ||
| This patent is subject to a terminal disclaimer. | ||
| Int. Cl. C12P 21/08 (2006.01) | ||
| U.S. Cl. 530—388.25 [530/387.1; 530/387.3; 530/388.15; 530/388.22] | 6 Claims |
| 1. A chimeric protein, which consists of an Fc region of immunoglobulin molecule fused at its amino terminus to a partial
protein of glycoprotein Ibα chain at its carboxyl terminus,
wherein said partial protein consists of amino acid residues 1-319 of glycoprotein Ibα chain, and
wherein the immunoglobulin is derived from human.
|